RAPID CITY, S.D. (7/25/2019) – Regional Health Rapid City Hospital will host the Abiomed Impella Mobile Learning Lab, an interactive learning experience to train hospital staff on the tiny Impella® heart pump, on Thursday, Aug. 1.
The Mobile Learning Lab will be located in the hospital parking lot near the John T. Vucurevich Cancer Care Institute entrance, 353 Fairmont Blvd., throughout the day. Most of the time will be devoted to training for hospital physicians and caregivers; however, the public may tour the lab between 10 a.m. and 2 p.m.
Impella, the world’s smallest heart pump, is a minimally-invasive heart pump that assists the pumping functions of the heart during certain heart procedures. The catheter-like device is inserted into the heart from the femoral artery. Once in place, it pulls blood from the left ventricle through an inlet near the tip and expels blood into the ascending aorta.
Impella heart pumps provide treatment during elective, high-risk percutaneous coronary intervention (PCI) procedures and in the emergent treatment of cardiogenic shock, a condition that typically occurs during or after a heart attack. Impella is the only minimally-invasive heart pump that has been approved by the FDA for this use in the United States.
The Mobile Learning Lab offers cardiologists, nurses and cath lab staff at Regional Health Rapid City Hospital a chance to learn how these heart pumps can best be used for patients in critical need of cardiac support. The Mobile Learning Lab contains various Impella simulators, animations and key information, all presented by a team of Abiomed trainers.
ABOUT REGIONAL HEALTH
Headquartered in Rapid City, S.D., Regional Health is a community-based health care system with a mission to make a difference, every day. Regional Health offers care in 33 medical specialties and serves 20 communities across western South Dakota and in eastern Wyoming. With over 4,500 physicians and caregivers, Regional Health is comprised of 5 hospitals, 8 specialty and surgical centers and more than 40 medical clinics and health care service centers.
ABOUT IMPELLA HEART PUMPS
The Impella 2.5®, Impella CP®, Impella CP® with SmartAssist, and Impella 5.0® are FDA-approved heart pumps used to treat heart attack or cardiomyopathy patients in cardiogenic shock and have the unique ability to enable native heart recovery, allowing patients to return home with their own hearts. The Impella 2.5 and Impella CP devices are also FDA approved to treat certain advanced heart failure patients undergoing elective and urgent percutaneous coronary interventions (PCI) such as stenting or balloon angioplasty to reopen blocked coronary arteries. Abiomed’s right-side heart pump, the Impella RP® device, is approved to treat certain patients experiencing right heart failure. The Impella platform has supported more than 100,000 patients in the U.S., the EU, and Japan. To learn more about the Impella platform of heart pumps, including their approved indications and important safety and risk information associated with the use of the devices, please visit: www.protectedpci.com.
Strategic Marketing and Communications